Demonstrating Ligandability of the LC3A and LC3B Adapter Interface

Markus Hartmann, Jessica Huber, Jan S. Kramer, Jan Heering, Larissa Pietsch, Holger Stark, Dalibor Odadzic, Iris Bischoff, Robert Fürst, Martin Schröder, Masato Akutsu, Apirat Chaikuad, Volker Dötsch, Stefan Knapp, Ricardo M. Biondi, Vladimir V. Rogov, Ewgenij Proschak

Research output: Contribution to journalArticlepeer-review

13 Citations (Scopus)


Autophagy is the common name for a number of lysosome-based degradation pathways of cytosolic cargos. The key components of autophagy are members of Atg8 family proteins involved in almost all steps of the process, from autophagosome formation to their selective fusion with lysosomes. In this study, we show that the homologous members of the human Atg8 family proteins, LC3A and LC3B, are druggable by a small molecule inhibitor novobiocin. Structure-activity relationship (SAR) studies of the 4-hydroxy coumarin core scaffold were performed, supported by a crystal structure of the LC3A dihydronovobiocin complex. The study reports the first nonpeptide inhibitors for these protein interaction targets and will lay the foundation for the development of more potent chemical probes for the Atg8 protein family which may also find applications for the development of autophagy-mediated degraders (AUTACs).

Original languageEnglish
Pages (from-to)3720-3746
Number of pages27
JournalJournal of Medicinal Chemistry
Issue number7
Publication statusPublished - 2021 Apr 8
Externally publishedYes

ASJC Scopus subject areas

  • Molecular Medicine
  • Drug Discovery


Dive into the research topics of 'Demonstrating Ligandability of the LC3A and LC3B Adapter Interface'. Together they form a unique fingerprint.

Cite this